Anteris Technologies Global Corp. has 17 Schedule 13D or 13G filings on record since 2025-08-13. 5 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Medtronic plc | 16.2% | 15,652,173 | SCHEDULE 13D, 2026-01-29 | 2026-01-22 |
| L1 Capital Pty Ltd | 11.64% | 11,496,345 | SCHEDULE 13G/A, 2026-09-03 | 2026-08-31 |
| Fmr LLC | 7.5% | 7,325,169 | SCHEDULE 13G, 2026-08-06 | 2026-06-30 |
| Sio Capital Management, LLC | 5.54% | 5,382,965 | SCHEDULE 13G/A, 2026-05-04 | 2026-03-31 |
| BlackRock, Inc. | 5.01% | 4,879,068 | SCHEDULE 13G, 2026-04-27 | 2026-03-31 |
| Perceptive Advisors LLC | 4.7% | 1,705,130 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| Nantahala Capital Management, LLC | 4.08% | 3,995,579 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
Purpose of Transaction (Item 4)
Medtronic plc
The information set forth in Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. In connection with the Purchase Agreement, Anteris and Covidien entered into a Registration Rights Agreement (the "Registration Rights Agreement"), dated as of January 22, 2026. Pursuant to the Registration Rights Agreement, Anteris shall prepare and file with the Securities and Exchange Commission a registration statement covering the resale of all of the Shares not already covered by an existing and effective registration statement as soon as reasonably practicable and in any event no later than the 18th-month anniversary of the Closing Date (as defined in the Purchase Agreement) and indemnify, defend and hold harmless each holder of Shares in connection therewith. Anteris and Covidien also entered into an Investor Rights Agreement dated as of January 22, 2026 in connection with the Purchase Agreement (the "Investor Rights Agreement"). Pursuant to the Investor Rights Agreement, Covidien will have a participation right with respect to the issuance of certain of Anteris's securities. Further pursuant to the Investor Rights Agreement, Covidien shall have the right to designate one non-voting observer to the Anteris Board of Directors. The Investor Rights Agreement also contains transfer restrictions through May 22, 2027, an agreement to discuss potential collaborations, a customary standstill provision, a voting agreement, and a requirement upon …The first part of Item 4 of the SCHEDULE 13D filed 2026-01-29; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-13 | Sio Capital Management, LLC | 8.14% | SCHEDULE 13G/A |
| 2025-08-14 | Perceptive Advisors LLC | 4.7% | SCHEDULE 13G/A |
| 2025-10-17 | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2025-11-12 | L1 Capital Pty Ltd | 19.9% | SCHEDULE 13G/A |
| 2025-11-12 | Sio Capital Management, LLC | 4.92% | SCHEDULE 13G/A |
| 2025-11-14 | Nantahala Capital Management, LLC | 5.32% | SCHEDULE 13G |
| 2026-01-21 | BlackRock, Inc. | 4.9% | SCHEDULE 13G/A |
| 2026-01-29 | Medtronic plc | 16.2% | SCHEDULE 13D |
| 2026-02-05 | L1 Capital Pty Ltd | 13.6% | SCHEDULE 13G/A |
| 2026-02-13 | Nantahala Capital Management, LLC | 7.52% | SCHEDULE 13G/A |
| 2026-04-27 | BlackRock, Inc. | 5.01% | SCHEDULE 13G |
| 2026-05-04 | Sio Capital Management, LLC | 5.54% | SCHEDULE 13G/A |
| 2026-05-15 | Nantahala Capital Management, LLC | 6.28% | SCHEDULE 13G/A |
| 2026-08-06 | Fmr LLC | 7.5% | SCHEDULE 13G |
| 2026-08-07 | L1 Capital Pty Ltd | 13.46% | SCHEDULE 13G/A |
| 2026-08-14 | Nantahala Capital Management, LLC | 4.08% | SCHEDULE 13G/A |
| 2026-09-03 | L1 Capital Pty Ltd | 11.64% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Anteris Technologies Global Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.